Damien Thomson - Concepedia

Author

Damien Thomson

Also Known As

A. McDonald, D B Thomson, D Thomson, D. B. THOMSON, D. B. Thomson, D. Thomson, D.B Thomson, D.B. Thomson, Damien B Thomson, Damien B. Thomson

Publications

2.3K

Citations

H-Index

Concepts

All Affiliations

Princess Alexandra Hospital The University of Queensland Peter MacCallum Cancer Centre Royal North Shore Hospital Royal Brisbane and Women's Hospital

About

Damien Thomson is an author at Princess Alexandra Hospital specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	19	1.3K
2	Health Sciences	6	6	614
3	Immunology	3	3	122
4	Social Sciences	2	2	134
5	Gastroenterology	1	1	66

Damien Thomson

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
Is concurrent radiation therapy required in patients receiving preoperative chemotherapy for adenocarcinoma of the oesophagus? A randomised phase II trial Bryan Burmeister, Janine Thomas, Elizabeth Burmeister, European Journal of Cancer Preoperative ChemotherapySurgical OncologyEsophageal CancerRadiation TherapyMedicine	2010	325
Phase II study of single-agent panitumumab in patients with incurable cutaneous squamous cell carcinoma Matthew Foote, Margaret McGrath, Alexander Guminski, Annals of Oncology MedicineSingle-agent PanitumumabPathologyPhase Ii StudyImmune Checkpoint Inhibitor	2014	159
Body Weight and Prognosis in Breast Cancer<xref ref-type="fn" rid="FN2">2</xref><xref ref-type="fn" rid="FN3">3</xref><xref ref-type="fn" rid="FN4">4</xref> N F Boyd, J E Campbell, T Germanson, JNCI Journal of the National Cancer Institute	1981	135
Enhanced toxicity with concurrent cetuximab and radiotherapy in head and neck cancer David Pryor, Sandro Porceddu, Bryan Burmeister, Radiotherapy and Oncology Neck CancerRadiation TherapyMedicineRadiopharmaceutical TherapyConcurrent Cetuximab	2008	123
A phase II study of the heparanase inhibitor PI-88 in patients with advanced melanoma Karl D. Lewis, William A. Robinson, Michael Millward, Investigational New Drugs Heparanase Inhibitor Pi-88MedicineMelanomaPathologyPhase Ii Study	2007	92
Comparison of Two Standard Chemotherapy Regimens for Good-Prognosis Germ Cell Tumors: Updated Analysis of a Randomized Trial Peter Grimison, Martin R. Stockler, Damien Thomson, JNCI Journal of the National Cancer Institute	2010	76
Refining Esophageal Cancer Staging After Neoadjuvant Therapy: Importance of Treatment Response Andrew P. Barbour, Mark Jones, Mithat Gönen, Annals of Surgical Oncology Esophageal Cancer StagingEsophagusEsophageal CancerNeoadjuvant TherapyGastrointestinal Oncology	2008	70
Psychological responses to malignant melanoma Brian Kelly, Beverley Raphael, B. Mark Smithers, General Hospital Psychiatry Psychological Co-morbiditiesPsychopathologyPsychosocial DeterminantPsychologyPsychological Responses	1995	69
A prospective study of cisplatin-based combination chemotherapy in advanced germ cell malignancy: role of maintenance and long-term follow-up. John A. Levi, Damien Thomson, T Sandeman, Journal of Clinical Oncology Cisplatin-based Combination ChemotherapySurgical OncologyLong-term Follow-upMalignant DiseaseGenitourinary Cancer	1988	66
Positron emission tomography and pathological evidence of response to neoadjuvant therapy in adenocarcinoma of the esophagus B. Mark Smithers, G. C. Couper, Janine Thomas, Diseases of the Esophagus Surgical OncologyEsophageal CancerNeoadjuvant TherapyGastroenterologyPathology	2007	66

Page 1